incid
morbid
mortal
bronchiti
pneumonia
high
older
adult
increas
ageth
clinic
manifest
bronchiti
pneumonia
older
adult
may
typic
eg
cough
fever
dyspnea
mani
older
adult
particularli
nurs
home
resid
may
present
alter
mental
statu
without
fever
obtain
chest
xray
often
critic
make
distinct
two
clinic
entitiesuniqu
risk
factor
pneumonia
older
adult
includ
multipl
comorbid
eg
copd
dm
chf
poor
oral
hygien
lack
vaccin
eg
pneumonia
influenza
swallow
difficultyempir
treatment
decis
pneumonia
base
site
care
recent
inform
suggest
inhom
therapi
commun
dweller
therapi
within
nurs
home
longterm
care
resid
feasibl
good
outcom
select
patientsprevent
strategi
pneumonia
target
toward
provid
vaccin
improv
oral
hygien
improv
swallow
difficulti
chronic
bronchiti
affect
patient
chronic
obstruct
pulmonari
diseas
copd
character
chronic
cough
product
sputum
last
month
year
consecut
year
chronic
bronchiti
usual
result
smokingrel
obstruct
diseas
although
mani
elderli
patient
chronic
bronchiti
may
exsmok
agerel
declin
lung
function
also
precipit
copd
symptom
elderli
patient
chronic
bronchiti
acut
exacerb
chronic
bronchiti
aecb
common
aecb
defin
worsen
short
breath
cough
andor
sputum
product
account
daili
variabl
requir
chang
therapi
aecb
lead
poor
qualiti
life
loss
function
statu
hospit
loss
lung
function
often
fatal
elderli
patient
risk
factor
aecb
includ
respiratori
infect
environment
exposur
eg
air
pollut
poor
complianc
prescrib
copd
therapi
lower
respiratori
tract
infect
often
trigger
aecb
account
episod
viral
infect
includ
influenza
parainfluenza
rhinovirus
account
exacerb
associ
superimpos
bacteri
infect
well
streptococcu
pneumonia
haemophilu
influenza
moraxella
catarrhali
common
pathogen
mild
case
aecb
account
case
sever
case
aecb
requir
mechan
ventil
enter
gramneg
bacilli
includ
pseudomona
stenotrophomona
spp
identifi
atyp
pathogen
mostli
chlamydia
pneumonia
implic
case
elderli
patient
symptom
sign
aecb
includ
increas
sputum
product
andor
sputum
purul
worsen
dyspnea
cough
onset
worsen
fluid
retent
fever
tachycardia
alter
mental
statu
increas
age
comorbid
condit
cardiac
diseas
malnutrit
underli
sever
copd
increas
risk
hospit
treatment
failur
diagnosi
aecb
often
made
clinic
find
howev
suffici
sputum
product
sputum
specimen
gram
stain
cultur
help
guid
antimicrobi
treatment
decis
elderli
patient
symptom
aecb
may
present
sputum
often
produc
empir
treatment
initi
chest
radiograph
obtain
especi
abnorm
breath
sound
differenti
aecb
pneumonia
main
goal
treat
aecb
allow
rapid
symptom
relief
erad
caus
pathogen
decreas
likelihood
futur
recurr
preserv
lung
function
earli
studi
effect
antibacteri
treatment
aecb
inconclus
howev
recent
clinic
trial
shown
antimicrobi
therapi
effect
administ
riskstratifi
group
algorithm
empir
treatment
decis
elderli
patient
aecb
provid
fig
renal
clearanc
may
declin
certain
antibiot
age
elderli
patient
may
need
treat
chronic
renal
insuffici
therapeut
intervent
includ
supplement
oxygen
need
bronchodil
rest
fluid
optim
nutrit
judici
use
corticosteroid
earli
administr
neuraminidas
inhibitor
influenza
infect
confirm
treatment
right
heart
failur
present
pulmonari
rehabilit
program
improv
baselin
lung
function
elderli
patient
chronic
bronchiti
therebi
prevent
futur
episod
smoke
cessat
critic
also
lead
attenu
diseas
progress
pneumococc
influenza
vaccin
often
administ
prevent
upper
lower
respiratori
tract
infect
detail
vaccin
present
section
pneumonia
prevent
pneumonia
lead
caus
morbid
mortal
older
adult
incid
pneumonia
increas
age
almost
half
infecti
diseas
hospit
death
associ
pneumonia
older
adult
rate
age
year
remain
consist
high
rate
hospit
pneumonia
among
older
adult
age
increas
time
overal
rate
communityacquir
pneumonia
cap
person
age
year
rang
case
per
personyear
case
per
personyear
among
age
year
result
estim
episod
per
year
cap
adult
year
unit
state
resid
nurs
home
age
year
older
rate
nurs
home
acquir
pneumonia
nhap
high
case
per
personyear
pneumonia
classifi
four
categori
communityacquir
pneumonia
cap
hospitalacquir
pneumonia
hap
nurs
home
acquir
pneumonia
nhap
healthcareassoci
pneumonia
hcap
ventilatorassoci
pneumonia
vap
cap
hap
differenti
pneumonia
develop
patient
outpati
inpati
set
respect
vap
defin
pneumonia
aris
patient
receiv
least
h
mechan
ventil
nhap
occur
nurs
home
resid
acquir
pneumonia
resid
nurs
home
sinc
increas
number
patient
especi
elderli
patient
util
rehabilit
facil
outpati
surgic
center
dialysi
center
pneumonia
acquir
patient
util
facil
consid
hcap
epidemiolog
hcap
close
resembl
hap
sinc
patient
truli
resid
commun
cap
among
senior
age
male
sex
copd
immunosuppress
smoke
cancer
previou
hospit
pneumonia
identifi
risk
factor
function
statu
time
hospit
admiss
shown
power
predictor
mortal
among
nurs
home
resid
inadequ
oral
care
swallow
difficulti
lack
influenza
vaccin
shown
modifi
risk
factor
nhap
malnutrit
also
implic
potenti
risk
factor
pneumonia
nurs
home
resid
specif
nurs
home
resid
low
serum
zinc
concentr
increas
incid
durat
pneumonia
increas
number
new
antibiot
prescript
day
antibiot
use
resid
normal
serum
zinc
concentr
common
etiolog
pneumonia
older
adult
depend
site
acquisit
predomin
pathogen
senior
site
streptococcu
pneumonia
cap
often
treat
outpati
set
common
pathogen
includ
streptococcu
pneumonia
mycoplasma
pneumonia
haemophilu
influenza
chlamydia
pneumonia
respiratori
virus
e
g
influenza
b
adenoviru
respiratori
syncyti
viru
rsv
parainfluenza
human
metapneumoviru
mycoplasma
pneumonia
chlamydia
pneumonia
common
caus
cap
younger
adult
unknown
preval
pathogen
elderli
sever
cap
greater
requir
inpati
therapi
list
pathogen
legionella
speci
staphylococcu
aureu
secondari
infect
influenza
pneumonia
consid
patient
hcap
staphylococcu
aureu
methicillinsuscept
methicillinresist
identifi
larg
proport
patient
gramneg
bacteria
pneumonia
eg
pseudomona
speci
klebsiella
speci
common
hap
nhap
vap
communitydwel
older
adult
preexist
lung
diseas
particularli
high
aspir
risk
outbreak
set
legionella
pneumophila
chlamydia
pneumonia
rsv
influenza
parainfluenza
strongli
consid
pathogen
consid
older
adult
includ
mycobacteri
diseas
reactiv
mycobacterium
tuberculosi
three
four
time
higher
nurs
home
resid
commun
dweller
mycobacterium
avium
intracellular
complex
caus
agent
mani
evolv
destruct
pulmonari
infect
often
nonsmok
older
women
present
cough
fatigu
fever
weight
loss
nonspecif
pulmonari
infiltr
human
immunodefici
viru
hiv
infect
opportunist
pulmonari
infect
pneumocysti
jiroveci
formerli
known
carinii
pneumonia
tuberculosi
cryptococcosi
increasingli
report
older
adult
advanc
highli
activ
antiretrovir
therapi
hivinfect
individu
live
longer
older
adult
often
develop
opportunist
pulmonari
infect
associ
hiv
treatment
failur
see
also
chapter
human
immunodefici
virusacquir
syndrom
opportunist
infect
nocardia
asteroid
pulmonari
aspergillosi
consid
older
adult
malnutrit
progress
weight
loss
evolv
pulmonari
infiltr
primari
mechan
pneumonia
cap
nhap
bronchoaspir
approxim
half
healthi
adult
aspir
small
amount
oropharyng
secret
sleep
sinc
healthi
adult
colon
virul
pathogen
oropharynx
sinc
forc
cough
intact
ciliari
transport
normal
humor
cellular
immun
mechan
present
healthi
adult
often
protect
repeat
episod
pneumonia
howev
older
adult
higher
frequenc
silent
aspir
particularli
dementia
stroke
physiolog
chang
decreas
elast
recoil
lung
decreas
complianc
chest
wall
decreas
respiratori
muscl
strength
calcif
within
rib
cage
osteoporosi
result
vertebr
fractur
decreas
mucociliari
clearanc
rate
swallow
difficulti
associ
age
addit
older
adult
tend
colon
upper
respiratori
tract
virul
pathogen
enterobacteriacea
pseudomona
aeruginosa
staphylococcu
aureu
combin
higher
rate
aspir
impair
airway
defens
mechan
colon
pathogen
organ
make
older
adult
greater
risk
develop
pneumonia
pneumonia
acut
inflamm
character
accumul
neutrophil
plasma
exud
alveolar
space
pulmonari
capillari
uninfect
lung
neutrophil
remain
trap
readi
respond
need
pulmonari
infect
neutrophil
migrat
alveolar
space
kill
microb
primarili
phagocytosi
mani
plasma
protein
present
exud
serv
opson
bacteriostat
microbicid
function
well
infect
critic
inflamm
innat
immun
host
defens
also
directli
injur
lung
result
acut
lung
injuri
older
adult
inflammatori
respons
elicit
highli
pathogen
organ
add
sever
diseas
experienc
popul
cough
sputum
product
chill
pleurit
chest
pain
commonli
seen
among
patient
cap
elderli
nurs
home
resid
nhap
often
present
alter
mental
statu
without
fever
classic
triad
cough
fever
dyspnea
seen
older
patient
cap
tachypnea
respiratori
rate
breathsmin
tachycardia
heart
rate
beatsmin
seen
twothird
elderli
patient
pneumonia
sign
may
preced
clinic
featur
day
mani
elderli
patient
particularli
chronic
debilit
may
present
subtl
clinic
manifest
aggrav
preexist
comorbid
eg
diabet
chf
unexplain
fall
failur
thrive
poor
appetit
older
patient
l
pneumophila
frequent
caus
atyp
pneumonia
syndrom
present
constitut
symptom
myalgia
diarrhea
alter
mental
statu
bradycardia
hyponatremia
none
sign
symptom
specif
l
pneumophila
provid
insight
caus
pathogen
diagnosi
cap
made
suggest
clinic
featur
eg
cough
fever
sputum
product
pleurit
chest
pain
demonstr
infiltr
chest
radiograph
physic
examin
find
eg
bronchial
breath
sound
rale
import
less
sensit
specif
chest
radiograph
find
older
adult
may
lack
clinic
featur
andor
physic
examin
find
therefor
chest
radiograph
import
differenti
cap
acut
bronchiti
older
adult
routin
diagnost
test
identifi
etiolog
agent
option
outpati
cap
sinc
patient
well
empir
antibiot
therapi
pretreat
blood
cultur
expector
sputum
specimen
gram
stain
cultur
standard
sampl
obtain
howev
pretreat
blood
cultur
identifi
probabl
pathogen
patient
cap
yield
blood
cultur
highest
patient
sever
cap
pathogen
organ
aureu
p
aeruginosa
gramneg
bacilli
identifi
sinc
pathogen
commonli
identifi
older
adult
blood
cultur
part
standard
diagnost
evalu
older
adult
cap
clinic
indic
extens
etiolog
diagnost
test
list
tabl
mani
diagnost
test
determin
etiolog
pneumonia
requir
sputum
product
often
older
adult
difficulti
produc
sputum
nevertheless
diagnost
test
particularli
import
result
may
alter
antibiot
manag
decis
outbreak
must
identifi
eg
sever
acut
respiratori
syndrom
sar
influenza
legionnair
diseas
agent
bioterror
epidemiolog
implic
eg
emerg
resist
pathogen
clinic
util
sputum
cultur
result
larg
depend
qualiti
sputum
specimen
whether
specimen
obtain
prior
antimicrobi
therapi
sputum
difficult
obtain
urinari
antigen
test
pneumonia
l
pneumophila
serogroup
assist
make
diagnosi
test
higher
diagnost
yield
patient
sever
diseas
advantag
test
includ
rapid
result
abil
detect
antigen
even
initi
antibiot
therapi
high
specif
legionella
commerci
avail
urinari
antigen
assay
detect
serogroup
although
serogroup
account
communityacquir
case
legionnair
serogroup
would
detect
standard
urinari
antigen
assay
influenza
b
adenoviru
rsv
parainfluenza
human
metapneumoviru
direct
fluoresc
antibodi
test
perform
rapidli
nasopharyng
sampl
assist
determin
whether
antivir
antimicrobi
therapi
warrant
patient
hap
requir
mechan
ventil
postintub
tracheal
aspir
shown
reliabl
microbiolog
diagnosi
compar
bronchoalveolar
lavag
bal
plug
telescop
cathet
protect
specimen
brush
procedur
particularli
older
adult
prognost
score
system
help
predict
outcom
therapi
score
system
predict
mortal
howev
assess
clinic
outcom
physic
function
abil
cognit
abil
need
nurs
home
care
overal
qualiti
life
import
outcom
older
adult
pneumonia
sever
index
psi
deriv
valid
fine
et
al
twostep
variabl
score
system
best
identifi
patient
treat
outpati
howev
mani
older
adult
fall
highrisk
group
pure
base
age
therefor
use
predict
treatment
outcom
group
patient
lim
et
al
deriv
valid
modifi
version
score
system
british
thorac
societi
system
consist
five
paramet
confus
uremia
respiratori
rate
low
blood
pressur
age
year
shown
use
emerg
depart
simplic
use
abil
identifi
lowrisk
patient
modif
account
age
year
higher
blood
urea
level
identifi
older
cohort
sever
pneumonia
one
score
system
deriv
valid
among
senior
year
age
five
featur
independ
predict
hospit
mortal
age
year
impair
motor
respons
creatinin
level
mgdl
presenc
coexist
diseas
extrem
vital
sign
score
system
age
year
shown
greatest
predictor
mortal
current
score
system
exist
predict
outcom
mortal
care
older
adult
pneumonia
sever
observ
studi
nurs
home
popul
document
declin
function
pneumonia
prospect
studi
nurs
home
resid
lower
respiratori
tract
infect
incid
declin
function
statu
declin
function
statu
day
pneumonia
episod
less
like
recov
baselin
statu
day
similarli
larg
prospect
trial
older
adult
function
declin
occur
rapidli
among
subject
develop
infect
dose
respons
increas
risk
declin
number
infecti
episod
increas
prognost
score
system
particularli
may
help
easili
identifi
patient
treat
outpati
howev
patient
score
hospit
intens
inhom
health
care
servic
usual
warrant
patient
septic
shock
requir
vasopressor
acut
respiratori
failur
requir
intub
mechan
ventil
usual
direct
admiss
intens
care
unit
howev
among
older
adult
assess
goal
care
often
warrant
initi
hospit
andor
intens
care
unit
icu
admiss
patient
cap
hospitalathom
servic
shown
feasibl
safe
efficaci
cost
effect
hospit
admiss
addit
hospitalathom
associ
lower
level
famili
member
stress
appear
shift
burden
care
hospit
staff
famili
member
icu
admiss
warrant
older
adult
comfort
main
goal
care
nurs
home
resid
nhap
random
control
trial
clinic
pathway
treatment
nhap
nurs
home
versu
hospit
result
compar
clinic
outcom
reduc
hospit
health
care
cost
clinic
pathway
group
hospit
hospit
usual
care
group
result
greater
proport
reduct
hospit
mortal
rate
death
clinic
pathway
group
versu
death
usual
care
group
signific
differ
qualiti
life
function
statu
two
group
overal
cost
save
util
clinic
pathway
per
resid
ci
although
studi
demonstr
treatment
pneumonia
nurs
home
reduc
hospit
cost
resid
met
follow
criteria
could
treat
nurs
home
studi
purpos
puls
less
respiratori
rate
less
systol
blood
pressur
least
mm
hg
oxygen
satur
least
resid
copd
abil
eat
drink
one
criteria
met
resid
transfer
hospit
addit
studi
conduct
canada
sinc
unit
state
differ
healthcar
financ
system
gener
clinic
pathway
treat
pneumonia
nurs
home
may
feasibl
unit
state
nevertheless
studi
demonstr
proof
principl
approach
warrant
consider
resid
mild
moder
pneumonia
healthi
older
adult
comorbid
empir
treatment
outpati
cap
initi
macrolid
doxycyclin
howev
senior
comorbid
chronic
heart
lung
liver
renal
diseas
diabet
mellitu
alcohol
immunosuppress
respiratori
quinolon
eg
moxifloxacin
levofloxacin
plu
macrolid
initi
outpati
inpati
cap
treatment
retrospect
data
suggest
patient
sever
cap
treat
plu
macrolid
may
improv
clinic
outcom
compar
patient
treat
respiratori
quinolon
pseudomona
aeruginosa
concern
antipneumococc
antipseudomon
eg
piperacillintazobactam
cefepim
imipenem
meropenem
consid
doubl
coverag
ciprofloxacin
levofloxacin
consid
well
aminoglycosid
often
recommend
doubl
coverag
pseudomona
howev
older
adult
decreas
glomerular
filtrat
rate
aminoglycosid
administ
cautious
nephrotox
effect
communityacquir
mrsa
consider
vancomycin
linezolid
ad
nurs
home
resid
older
adult
hap
hcap
vap
antipseudomon
coverag
mrsa
coverag
may
warrant
empir
therefor
common
empir
regimen
treatment
hap
hcap
vap
piperacillintazobactam
vancomycin
howev
drugresist
pneumonia
becom
increasingli
preval
age
year
identifi
risk
factor
pneumonia
resist
penicillin
cephalosporin
appear
decreas
macrolid
resist
continu
increas
repeat
use
fluoroquinolon
predict
increas
risk
infect
fluoroquinoloneresist
pneumococci
nurs
home
resid
particular
usual
expos
multipl
cours
antibiot
therapi
higher
risk
harbor
drugresist
pneumococci
gram
neg
aureu
empir
therapi
piperacillintazobactam
vancomycin
result
treatment
failur
vigor
attempt
made
identifi
caus
pathogen
broaden
antibiot
coverag
carbapenem
may
warrant
nurs
home
resid
transfer
hospit
facil
empir
treat
nhap
nurs
home
intramuscular
oncedaili
cefepim
shown
clinic
success
costeffect
ceftriaxon
particip
receiv
cefepim
receiv
ceftriaxon
could
evalu
clinic
success
occur
cefepim
ceftriaxonetr
patient
p
mean
antibiot
cost
cefepim
ceftriaxonetr
patient
p
resid
empir
ceftriaxon
therapi
would
use
intramuscular
cefepim
nurs
home
consid
treatment
nurs
home
set
prefer
oral
antimicrobi
agent
ciprofloxacin
administ
cover
caus
pathogen
etiolog
pneumonia
identifi
antimicrobi
therapi
direct
pathogen
list
prefer
altern
antimicrobi
agent
common
pathogen
identifi
older
adult
provid
tabl
sinc
mani
older
adult
colon
drugresist
organ
extend
spectrum
esbl
produc
organ
increasingli
isol
ertapenem
newer
carbapenem
narrow
spectrum
activ
meropenem
imipenem
shown
clinic
util
vap
older
adult
mainstay
prevent
pneumonia
older
adult
pneumococc
influenza
vaccin
per
center
diseas
control
prevent
guidelin
person
age
older
receiv
pneumococc
vaccin
revaccin
recommend
unless
first
dose
administ
age
case
revaccin
occur
age
year
pass
sinc
vaccin
sinc
influenzarel
death
occur
among
peopl
age
least
year
yearli
influenza
vaccin
recommend
howev
actual
benefit
influenza
vaccin
older
adult
controversi
even
vaccin
coverag
increas
recent
excess
mortal
studi
demonstr
declin
influenzarel
mortal
sinc
impair
antibodi
respons
thought
contribut
stabl
mortal
rate
booster
influenza
vaccin
shown
augment
antibodi
respons
among
nurs
home
resid
impair
respons
initi
vaccin
howev
improv
seroprotect
rate
shown
decreas
hospit
rate
death
antibiot
use
year
without
circul
influenza
one
possibl
explan
poor
respons
influenza
vaccin
agerel
impair
innat
immun
specif
tolllik
receptor
tlr
mediat
express
costimulatori
molecul
critic
vaccin
immun
therefor
yearli
influenza
vaccin
current
recommend
futur
attempt
improv
vaccin
strategi
warrant
sinc
inadequ
oral
care
swallow
difficulti
identifi
independ
modifi
risk
factor
nhap
intervent
target
toward
improv
oral
hygien
swallow
eg
mechan
oral
care
oral
chlorhexidin
rins
need
test
determin
whether
reduc
incid
pneumonia
recent
pilot
evalu
two
nurs
home
demonstr
mechan
oral
care
ie
teeth
andor
dentur
oral
caviti
brush
plu
oral
chlorhexidin
rins
feasibl
perform
certifi
nurs
aid
adher
nurs
staff
effect
improv
oral
hygien
ie
reduct
oral
plaqu
score
swallow
difficulti
vincent
quagliarello
addit
intervent
improv
swallow
need
investig
well
tradit
chines
herbal
medicin
banxia
houpu
tang
bht
found
improv
swallow
reflex
patient
stroke
parkinson
diseas
test
random
control
trial
among
elderli
nurs
home
resid
found
reduc
risk
pneumonia
pneumoniarel
mortal
like
combin
intervent
improv
oral
hygien
swallow
difficulti
greatest
potenti
reduc
burden
pneumonia
nurs
home
resid
futur
studi
determin
whether
similar
strategi
reduc
burden
pneumonia
elderli
commun
dweller
